{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T07:01:22Z","timestamp":1783062082517,"version":"3.54.6"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2834,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1111\/j.1365-2133.2007.08308.x","type":"journal-article","created":{"date-parts":[[2010,7,22]],"date-time":"2010-07-22T09:08:56Z","timestamp":1279789736000},"page":"122-129","source":"Crossref","is-referenced-by-count":39,"title":["A randomized, single-blind comparison of topical clindamycin + benzoyl peroxide and adapalene in the treatment of mild to moderate facial acne vulgaris"],"prefix":"10.1093","volume":"158","author":[{"given":"A.","family":"Langner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Goulden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Ambroziak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2007,11,28]]},"reference":[{"key":"10.1111\/j.1365-2133.2007.08308.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3810\/pgm.2000.03.945","article-title":"Topical therapy for acne vulgaris. How do you choose the best drug for each patient?","volume":"107","author":"Johnson","year":"2000","journal-title":"Postgrad Med"},{"issue":"Suppl. 1","key":"10.1111\/j.1365-2133.2007.08308.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1067\/mjd.2003.618","article-title":"Management of acne: a report from a global alliance to improve outcomes in acne","volume":"49","author":"Gollnick","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2007.08308.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1046\/j.1365-2133.2003.05067.x","article-title":"Antibiotic-resistant acne: lessons from Europe","volume":"148","author":"Ross","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2007.08308.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/j.1365-2133.1992.tb00104.x","article-title":"Antibiotic resistance patterns on coagulase-negative staphylococci after treatment with topical erythromycin, benzoyl peroxide, and combination therapy","volume":"126","author":"Harkaway","year":"1992","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2007.08308.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"813","DOI":"10.2165\/00128071-200304120-00002","article-title":"Is antibiotic resistance in cutaneous propionibacteria clinically relevant? Implications of resistance for acne patients and prescribers","volume":"4","author":"Eady","year":"2003","journal-title":"Am J Clin Dermatol"},{"key":"10.1111\/j.1365-2133.2007.08308.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/S0190-9622(97)70177-4","article-title":"Treatment of acne with a combination clindamycin\/benzoyl peroxide gel compared with clindamycin gel, benzoyl peroxide gel and vehicle gel: combined results of two double blind investigations","volume":"37","author":"Lookingbill","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2007.08308.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2165\/00128071-200102040-00007","article-title":"The combination formulation of clindamycin 1% plus benzoyl peroxide 5% versus 3 different formulations of topical clindamycin alone in the reduction of Propionibacterium acnes","volume":"2","author":"Leyden","year":"2001","journal-title":"Am J Clin Dermatol"},{"key":"10.1111\/j.1365-2133.2007.08308.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S0149-2918(02)80023-6","article-title":"A randomised, double-blind comparison of a clindamycin phosphate\/benzoyl peroxide gel formulation and a matching clindamycin gel with respect to microbiologic activity and clinical efficacy in the topical treatment of acne vulgaris","volume":"24","author":"Cunliffe","year":"2002","journal-title":"Clin Ther"},{"key":"10.1111\/j.1365-2133.2007.08308.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S0190-9622(83)70211-2","article-title":"A double-blind study of the effectiveness of a 3% erythromycin and 5% benzoyl peroxide combination in the treatment of acne vulgaris","volume":"9","author":"Chalker","year":"1983","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2007.08308.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1365-2133.1996.tb07847.x","article-title":"The effect of acne treatment with a combination of benzoyl peroxide and erythromycin on skin carriage of erythromycin-resistant propionibacteria","volume":"134","author":"Eady","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2007.08308.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000017844","article-title":"Topical drug treatment in acne","volume":"196","author":"Gollnick","year":"1998","journal-title":"Dermatology"},{"key":"10.1111\/j.1365-2133.2007.08308.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"511","DOI":"10.2165\/00003495-199753030-00010","article-title":"Adapalene: a review of its pharmacological properties and clinical potential in the management of mild to moderate acne","volume":"53","author":"Brogden","year":"1997","journal-title":"Drugs"},{"issue":"Suppl. 52","key":"10.1111\/j.1365-2133.2007.08308.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1046\/j.1365-2133.1998.1390s2003.x","article-title":"Pharmacology of adapalene","volume":"139","author":"Michel","year":"1998","journal-title":"Br J Dermatol"},{"issue":"Suppl.","key":"10.1111\/j.1365-2133.2007.08308.x-BIB14|cit14","first-page":"123","article-title":"Regulation of human monocyte toll-like receptor 2 (TLR2) expression by adapalene","volume":"16","author":"Vega","year":"2002","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"Suppl.","key":"10.1111\/j.1365-2133.2007.08308.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"S126","DOI":"10.1016\/S0190-9622(97)70056-2","article-title":"Clinical efficacy and safety comparison of adapalene gel and tretinoin gel in the treatment of acne vulgaris: Europe and US multicenter trials","volume":"36","author":"Cunliffe","year":"1997","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl. 52","key":"10.1111\/j.1365-2133.2007.08308.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1046\/j.1365-2133.1998.1390s2048.x","article-title":"A comparison of the efficacy and tolerability of adapalene 0.1% gel versus tretinoin 0.025% gel in patients with acne vulgaris: a meta-analysis of five randomized trials","volume":"139","author":"Cunliffe","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2007.08308.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3109\/09546639809160698","article-title":"The Leeds revised acne grading system","volume":"9","author":"O\u2019Brien","year":"1989","journal-title":"J Dermatolog Treat"},{"key":"10.1111\/j.1365-2133.2007.08308.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/jid.1965.164","article-title":"A new method for the quantitative investigation of cutaneous bacteria","volume":"45","author":"Williamson","year":"1965","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.2007.08308.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1159\/000017851","article-title":"Why and when the treatment of acne fails; what to do","volume":"196","author":"Katsambas","year":"1998","journal-title":"Dermatology"},{"key":"10.1111\/j.1365-2133.2007.08308.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1540-9740.2003.02037.x","article-title":"How do you foster medication adherence for better acne vulgaris management?","volume":"2","author":"Koo","year":"2003","journal-title":"Skinmed"},{"issue":"Suppl.","key":"10.1111\/j.1365-2133.2007.08308.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1016\/0190-9622(95)90419-0","article-title":"Patient compliance: enhancing clinician abilities and strategies","volume":"32","author":"Draelos","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2007.08308.x-BIB22|cit22","first-page":"408","article-title":"Objective assessment of compliance with psoriasis treatment","volume":"140","author":"Zahoul","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2007.08308.x-BIB23|cit23","first-page":"5","article-title":"Current concepts in the treatment of acne: report from a clinical roundtable","volume":"72","author":"Berson","year":"2003","journal-title":"Cutis"},{"key":"10.1111\/j.1365-2133.2007.08308.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0190-9622(81)70004-5","article-title":"Benzoyl peroxide: percutaneous penetration and metabolic disposition","volume":"4","author":"Nacht","year":"1981","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2007.08308.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1128\/AAC.33.3.326","article-title":"Role of lipids in augmenting the antibacterial activity of benzoyl peroxide against Propionibacterium acnes","volume":"33","author":"Decker","year":"1989","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1365-2133.2007.08308.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/1523-1747.ep12543487","article-title":"The effect of antimicrobial agents on leukocyte chemotaxis","volume":"70","author":"Esterly","year":"1978","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.2007.08308.x-BIB27|cit27","first-page":"164","article-title":"Clinical experience results with clindamycin 1%\/benzoyl peroxide 5% gel (Duac) as monotherapy and in combination","volume":"4","author":"Bikowski","year":"2005","journal-title":"J Drugs Dermatol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2007.08308.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2133.2007.08308.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T14:23:29Z","timestamp":1676384609000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/158\/1\/122\/6641150"}},"subtitle":["Comparison of two treatments for facial acne"],"short-title":[],"issued":{"date-parts":[[2007,11,28]]},"references-count":27,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2133.2007.08308.x","relation":{},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"value":"0007-0963","type":"print"},{"value":"1365-2133","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,11,28]]}}}